Full-Time

Director – Analytical Sciences

Posted on 11/22/2024

Voyager Therapeutics

Voyager Therapeutics

201-500 employees

Develops genetic medicines for neurological diseases

Biotechnology
Healthcare

Expert

Lexington, MA, USA

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech

You match the following Voyager Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • MS or PhD in Biochemistry/Biology/Chemistry/Virology/Chemical Engineering or a related field
  • 13+ years (with MS) or 10+ years (with PhD) of relevant experience in industry – Protein therapeutics, gene therapy or viral vector assay experience in leading an analytical sciences group
  • Broad understanding of global expectations of Health Authorities (FDA, EMA, MHRA) in Pharmaceutical/Analytical Development and GxP regulations
  • Previous experience with good documentation practices
  • Significant attention to detail and accuracy in writing and following protocols
Responsibilities
  • Provide strong leadership and manage a team of scientists in analytical development – be responsible for setting of goals, execution of work, training, development and mentoring of colleagues
  • Follow budgetary considerations
  • Lead innovation, development and optimization of the analytical development processes including process analytics and method development
  • Lead/Develop protocols and associated execution for analytical science & bioassays method development to support the manufacture of Voyager pipeline and partner programs
  • Generate, manage, and maintain critical methods and data in a highly organized manner including experimental reports, SOPs, batch records, technology transfer documents, etc.
  • Act as the SME to maintain various external relationships with partners, vendors and CMOs/CROs for Analytical Science Development
  • Support and lead the transfer of developed analytical protocols and analytical processes to internal and external manufacturing partners
  • Lead/support process analytical activities associated with characterization, PPQ and authoring of relevant regulatory documents
  • Contribute to the execution of CMC projects through development of timelines, strategy and tools/workflows that can enable more streamlined execution
  • Contribute to scientific documentation of patent applications and subsequent internal and external presentation and/or publication of new technologies
Desired Qualifications
  • Demonstrated leadership experience including excellent communication, collaboration/consensus building, organizational awareness, and influencing and negotiation skills
  • Demonstrated ability to lead interdisciplinary projects, working in cross-functional matrix
  • Demonstrated personal accountability, ability to empower people and drive quality culture with partners demonstrating a high degree of mutual respect and integrity
  • Direct knowledge of a broad range of analytical methods (HPLC, ELISA, Mass Spec. etc.) through prior significant hands-on experience with a deep understanding of the methods
  • Experience with AAV ddPCR and potency assays is a plus

Voyager Therapeutics develops genetic medicines aimed at treating neurological diseases, particularly those affecting the central nervous system like amyotrophic lateral sclerosis (ALS). Their approach involves using a proprietary platform that utilizes adeno-associated virus (AAV) capsids to deliver genetic material directly to the brain through intravenous dosing, overcoming the challenge of the blood-brain barrier. Unlike many competitors, Voyager focuses on creating treatments that are specifically designed to address severe neurological conditions, and they emphasize collaboration with larger pharmaceutical companies to enhance their research and development efforts. The company's goal is to provide transformative therapies that significantly improve the lives of patients suffering from these debilitating diseases.

Company Stage

IPO

Total Funding

$102.1M

Headquarters

Cambridge, Massachusetts

Founded

2014

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Novartis could accelerate pipeline and expand market reach.
  • Electric pulse technology may enhance gene therapy delivery efficiency and reduce costs.
  • FDA approval of gene therapy for sickle cell disease may benefit Voyager's initiatives.

What critics are saying

  • Dependency on Novartis collaboration may affect Voyager's R&D autonomy.
  • Leadership changes may indicate potential instability or strategic shifts.
  • Reliance on milestone payments could create financial uncertainty if timelines are delayed.

What makes Voyager Therapeutics unique

  • Voyager's TRACER™ platform enhances CNS drug delivery by penetrating the blood-brain barrier.
  • The company focuses on gene therapies for CNS diseases like ALS and Parkinson's.
  • Voyager's proprietary AAV capsid discovery platform shows promise in preclinical studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

INACTIVE